{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T03:35:11Z","timestamp":1776569711398,"version":"3.51.2"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"7","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Infection with Helicobacter pylori is a major risk factor for chronic atrophic gastritis (CAG), a precursor lesion of intestinal gastric cancer. The pathogenicity of the bacterium is thought to play an important role in determining the extent and severity of clinical outcome. We aimed to assess the associations between CAG and the serostatus of antibodies to 15 H. pylori proteins. The analyses were based on 534 cases with serologically defined CAG and 1,068 age-matched and sex-matched controls participating in a population-based study conducted in Saarland, Germany among 9,953 men and women ages 50 to 74 years. A newly developed H. pylori multiplex serology method was used to detect antibodies specific to 15 H. pylori antigens. Significant associations were observed between seropositivity for all 15 specific antibodies and the presence of CAG. Exclusion of severe cases, who might have lost the infection in the course of CAG progression, substantially increased the observed associations. In H. pylori\u2013seropositive subjects, cytotoxin-associated gene A (CagA), vacuolating toxin (VacA), helicobacter cysteine-rich protein C (HcpC), and the chaperonin GroEL were identified as independent virulence factors for CAG with adjusted odds ratios (95% confidence interval) of 3.52 (2.01\u20136.10), 3.19 (1.44\u20137.05), 4.03 (1.53\u201310.65), and 2.65 (1.06\u20136.62), respectively; the simultaneous presence of all four independent virulence factors was associated with an 18-fold risk of CAG. In conclusion, HcpC and GroEL were identified as new independent virulence factors, and in combination with the established virulence factors, CagA and VacA, were strongly associated with CAG. [Cancer Res 2009;69(7):2973\u201380]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-3477","type":"journal-article","created":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T01:42:04Z","timestamp":1237945324000},"page":"2973-2980","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Association between Chronic Atrophic Gastritis and Serum Antibodies to 15 <i>Helicobacter pylori<\/i> Proteins Measured by Multiplex Serology"],"prefix":"10.1158","volume":"69","author":[{"given":"Lei","family":"Gao","sequence":"first","affiliation":[{"name":"1Clinical Epidemiology and Aging Research and Divisions of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie N.","family":"Weck","sequence":"additional","affiliation":[{"name":"1Clinical Epidemiology and Aging Research and Divisions of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Michel","sequence":"additional","affiliation":[{"name":"2Genome Modifications and Carcinogenesis, German Cancer Research Center, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pawlita","sequence":"additional","affiliation":[{"name":"2Genome Modifications and Carcinogenesis, German Cancer Research Center, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Brenner","sequence":"additional","affiliation":[{"name":"1Clinical Epidemiology and Aging Research and Divisions of"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2009,4,1]]},"reference":[{"key":"2022061701472023400_B1","doi-asserted-by":"crossref","unstructured":"Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet\u20081975; 2: 58\u201360.","DOI":"10.1016\/S0140-6736(75)90498-5"},{"key":"2022061701472023400_B2","doi-asserted-by":"crossref","unstructured":"Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol\u20082006; 20: 633\u201349.","DOI":"10.1016\/j.bpg.2006.04.008"},{"key":"2022061701472023400_B3","doi-asserted-by":"crossref","unstructured":"Peek RM, Jr., Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer\u20082002; 2: 28\u201337.","DOI":"10.1038\/nrc703"},{"key":"2022061701472023400_B4","doi-asserted-by":"crossref","unstructured":"Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther\u20081999; 3 Suppl 1: 3\u201311.","DOI":"10.1046\/j.1365-2036.1999.00002.x"},{"key":"2022061701472023400_B5","doi-asserted-by":"crossref","unstructured":"Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis\u20081990; 161: 626\u201333.","DOI":"10.1093\/infdis\/161.4.626"},{"key":"2022061701472023400_B6","doi-asserted-by":"crossref","unstructured":"Hamajima N, Naito M, Kondo T, Goto Y. Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci\u20082006; 97: 1129\u201338.","DOI":"10.1111\/j.1349-7006.2006.00290.x"},{"key":"2022061701472023400_B7","doi-asserted-by":"crossref","unstructured":"Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology\u20082007; 133: 659\u201372.","DOI":"10.1053\/j.gastro.2007.06.026"},{"key":"2022061701472023400_B8","doi-asserted-by":"crossref","unstructured":"Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science\u20081999; 284: 1328\u201333.","DOI":"10.1126\/science.284.5418.1328"},{"key":"2022061701472023400_B9","doi-asserted-by":"crossref","unstructured":"Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between CagA seropositivity and gastric cancer. Gastroenterology\u20082003; 125: 1636\u201344.","DOI":"10.1053\/j.gastro.2003.08.033"},{"key":"2022061701472023400_B10","doi-asserted-by":"crossref","unstructured":"Kuipers EJ, Pe\u0301rez-Pe\u0301rez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst\u20081995; 87: 1777\u201380.","DOI":"10.1093\/jnci\/87.23.1777"},{"key":"2022061701472023400_B11","doi-asserted-by":"crossref","unstructured":"Dhar SK, Soni RK, Das BK, Mukhopadhyay G. Molecular mechanism of action of major Helicobacter pylori virulence factors. Mol Cell Biochem\u20082003; 253: 207\u201315.","DOI":"10.1023\/A:1026051530512"},{"key":"2022061701472023400_B12","doi-asserted-by":"crossref","unstructured":"Lin YF, Wu MS, Chang CC, et al. Comparative immunoproteomics of identification and characterization of virulence factors from Helicobacter pylori related to gastric cancer. Mol Cell Proteomics\u20082006; 5: 1484\u201396.","DOI":"10.1074\/mcp.M600111-MCP200"},{"key":"2022061701472023400_B13","doi-asserted-by":"crossref","unstructured":"Mini R, Bernardini G, Salzano AM, et al. Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. J Chromatogr B Analyt Technol Biomed Life Sci\u20082006; 833: 63\u201379.","DOI":"10.1016\/j.jchromb.2005.12.052"},{"key":"2022061701472023400_B14","doi-asserted-by":"crossref","unstructured":"Haas G, Karaali G, Ebermayer K, et al. Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics\u20082002; 2: 313\u201324.","DOI":"10.1002\/1615-9861(200203)2:3<313::AID-PROT313>3.0.CO;2-7"},{"key":"2022061701472023400_B15","doi-asserted-by":"crossref","unstructured":"Kimmel B, Bosserhoff A, Frank R, Gross R, Goebel W, Beier D. Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect Immun\u20082000; 68: 915\u201320.","DOI":"10.1128\/IAI.68.2.915-920.2000"},{"key":"2022061701472023400_B16","doi-asserted-by":"crossref","unstructured":"Krah A, Miehlke S, Pleissner KP, et al. Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma. Int J Cancer\u20082004; 108: 456\u201363.","DOI":"10.1002\/ijc.11557"},{"key":"2022061701472023400_B17","doi-asserted-by":"crossref","unstructured":"Lu H, Yamaoka Y, Graham DY. Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol\u20082005; 21: 653\u20139.","DOI":"10.1097\/01.mog.0000181711.04529.d5"},{"key":"2022061701472023400_B18","doi-asserted-by":"crossref","unstructured":"Atanassov C, Pezennec L, d'Alayer J, Grollier G, Picard B, Fauche\u0300re JL. Novel antigens of Helicobacter pylori correspond to ulcer-related antibody pattern of sera from infected patients. J Clin Microbiol\u20082002; 40: 547\u201352.","DOI":"10.1128\/JCM.40.2.547-552.2002"},{"key":"2022061701472023400_B19","doi-asserted-by":"crossref","unstructured":"Brenner H, Rothenbacher D, Weck MN. Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value. Int J Cancer\u20082007; 121: 2782\u20136.","DOI":"10.1002\/ijc.22992"},{"key":"2022061701472023400_B20","doi-asserted-by":"crossref","unstructured":"Weck MN, Brenner H. Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev\u20082006; 15: 1083\u201394.","DOI":"10.1158\/1055-9965.EPI-05-0931"},{"key":"2022061701472023400_B21","doi-asserted-by":"crossref","unstructured":"Waterboer T, Sehr P, Michael KM, et al. Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins. Clin Chem\u20082005; 51: 1845\u201353.","DOI":"10.1373\/clinchem.2005.052381"},{"key":"2022061701472023400_B22","doi-asserted-by":"crossref","unstructured":"Karnes WE, Jr., Samloff IM, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology\u20081991; 101: 167\u201374.","DOI":"10.1016\/0016-5085(91)90474-Y"},{"key":"2022061701472023400_B23","doi-asserted-by":"crossref","unstructured":"Kokkola A, Kosunen TU, Puolakkainen P, et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS\u20082003; 111: 619\u201324.","DOI":"10.1034\/j.1600-0463.2003.1110604.x"},{"key":"2022061701472023400_B24","doi-asserted-by":"crossref","unstructured":"Sipponen P, Hyva\u0308rinen H, Seppa\u0308la\u0308 K, Blaser MJ. Review article: Pathogenesis of the transformation from gastritis to malignancy. Aliment Pharmacol Ther\u20081998; 12 Suppl 1: 61\u201371.","DOI":"10.1111\/j.1365-2036.1998.00005.x"},{"key":"2022061701472023400_B25","doi-asserted-by":"crossref","unstructured":"Mobley HL. Defining Helicobacter pylori as a pathogen: strain heterogeneity and virulence. Am J Med\u20081996; 100: 2\u20139S.","DOI":"10.1016\/S0002-9343(96)80223-3"},{"key":"2022061701472023400_B26","doi-asserted-by":"crossref","unstructured":"Torres J, Pe\u0301rez-Pe\u0301rez GI, Leal-Herrera Y, Mun\u0303oz O. Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico. Int J Cancer\u20081998; 78: 298\u2013300.","DOI":"10.1002\/(SICI)1097-0215(19981029)78:3<298::AID-IJC6>3.0.CO;2-Q"},{"key":"2022061701472023400_B27","doi-asserted-by":"crossref","unstructured":"Palli D, Masala G, Del Giudice G, et al. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer\u20082007; 120: 859\u201367.","DOI":"10.1002\/ijc.22435"},{"key":"2022061701472023400_B28","doi-asserted-by":"crossref","unstructured":"Eurohepygast Study Group. Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study. Gut\u20082002; 50: 779\u201385.","DOI":"10.1136\/gut.50.6.779"},{"key":"2022061701472023400_B29","doi-asserted-by":"crossref","unstructured":"Gwack J, Shin A, Kim CS, et al. CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea. Br J Cancer\u20082006; 95: 639\u201341.","DOI":"10.1038\/sj.bjc.6603309"},{"key":"2022061701472023400_B30","unstructured":"Rudi J, Kolb C, Maiwald M, et al. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci\u20081997; 42: 1652\u20139."},{"key":"2022061701472023400_B31","doi-asserted-by":"crossref","unstructured":"Ogura K, Maeda S, Nakao M, et al. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J Exp Med\u20082000; 192: 1601\u201310.","DOI":"10.1084\/jem.192.11.1601"},{"key":"2022061701472023400_B32","doi-asserted-by":"crossref","unstructured":"Shimoyama T, Neelam B, Fukuda S, Tanaka M, Munakata A, Crabtree JE. VacA seropositivity is not associated with the development of gastric cancer in a Japanese population. Eur J Gastroenterol Hepatol\u20081999; 11: 887\u201390.","DOI":"10.1097\/00042737-199908000-00013"},{"key":"2022061701472023400_B33","doi-asserted-by":"crossref","unstructured":"Harris AG, Wilson JE, Danon SJ, Dixon MF, Donegan K, Hazell SL. Catalase (KatA) and KatA-associated protein (KapA) are essential to persistent colonization in the Helicobacter pylori SS1 mouse model. Microbiology\u20082003; 149: 665\u201372.","DOI":"10.1099\/mic.0.26012-0"},{"key":"2022061701472023400_B34","doi-asserted-by":"crossref","unstructured":"Momynaliev KT, Rogov SI, Selezneva OV, Chelysheva VV, Akopian TA, Govorun VM. Comparative analysis of transcription profiles of Helicobacter pylori clinical isolates. Biochemistry Mosc\u20082005; 70: 383\u201390.","DOI":"10.1007\/s10541-005-0129-9"},{"key":"2022061701472023400_B35","doi-asserted-by":"crossref","unstructured":"Satin B, Del Giudice G, Della Bianca V, et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med\u20082000; 191: 1467\u201376.","DOI":"10.1084\/jem.191.9.1467"},{"key":"2022061701472023400_B36","doi-asserted-by":"crossref","unstructured":"Kavermann H, Burns BP, Angermuller K, et al. Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J Exp Med\u20082003; 197: 813\u201322.","DOI":"10.1084\/jem.20021531"},{"key":"2022061701472023400_B37","doi-asserted-by":"crossref","unstructured":"Sabarth N, Hurwitz R, Meyer TF, Bumann D. Multiparameter selection of Helicobacter pylori antigens identifies two novel antigens with high protective efficacy. Infect Immun\u20082002; 70: 6499\u2013503.","DOI":"10.1128\/IAI.70.11.6499-6503.2002"},{"key":"2022061701472023400_B38","doi-asserted-by":"crossref","unstructured":"Nystro\u0308m J, Svennerholm AM. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses. Vaccine\u20082007; 25: 2591\u20138.","DOI":"10.1016\/j.vaccine.2006.12.026"},{"key":"2022061701472023400_B39","doi-asserted-by":"crossref","unstructured":"Corthe\u0301sy-Theulaz IE, Hopkins S, Bachmann D, et al. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect Immun\u20081998; 66: 581\u20136.","DOI":"10.1128\/IAI.66.2.581-586.1998"},{"key":"2022061701472023400_B40","doi-asserted-by":"crossref","unstructured":"Kleanthous H, Myers GA, Georgakopoulos KM, et al. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun\u20081998; 66: 2879\u201386.","DOI":"10.1128\/IAI.66.6.2879-2886.1998"},{"key":"2022061701472023400_B41","doi-asserted-by":"crossref","unstructured":"Fischer W, Pu\u0308ls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol\u20082001; 42: 1337\u201348.","DOI":"10.1046\/j.1365-2958.2001.02714.x"},{"key":"2022061701472023400_B42","doi-asserted-by":"crossref","unstructured":"Kim N, Weeks DL, Shin JM, Scott DR, Young MK, Sachs G. Proteins released by Helicobacter pylori in vitro. J Bacteriol\u20082002; 184: 6155\u201362.","DOI":"10.1128\/JB.184.22.6155-6162.2002"},{"key":"2022061701472023400_B43","doi-asserted-by":"crossref","unstructured":"Mittl PR, Lu\u0308thy L, Reinhardt C, et al. Detection of high titers of antibody against Helicobacter cysteine-rich proteins A, B, C, and E in Helicobacter pylori-infected individuals. Clin Diagn Lab Immunol\u20082003; 10: 542\u20135.","DOI":"10.1128\/CDLI.10.4.542-545.2003"},{"key":"2022061701472023400_B44","doi-asserted-by":"crossref","unstructured":"Deml L, Aigner M, Decker J, et al. Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agent. Infect Immun\u20082005; 73: 4732\u201342.","DOI":"10.1128\/IAI.73.8.4732-4742.2005"},{"key":"2022061701472023400_B45","doi-asserted-by":"crossref","unstructured":"Park JW, Song JY, Lee SG, et al. Quantitative analysis of representative proteome components and clustering of Helicobacter pylori clinical strains. Helicobacter\u20082006; 11: 533\u201343.","DOI":"10.1111\/j.1523-5378.2006.00456.x"},{"key":"2022061701472023400_B46","doi-asserted-by":"crossref","unstructured":"Bergonzelli GE, Granato D, Pridmore RD, Marvin-Guy LF, Donnicola D, Corthe\u0301sy-Theulaz IE. GroEL of Lactobacillus johnsonii La1 (NCC 533) is cell surface associated: potential role in interactions with the host and the gastric pathogen Helicobacter pylori. Infect Immun\u20082006; 74: 425\u201334.","DOI":"10.1128\/IAI.74.1.425-434.2006"},{"key":"2022061701472023400_B47","doi-asserted-by":"crossref","unstructured":"Kansau I, Labigne A. Heat shock proteins of Helicobacter pylori. Aliment Pharmacol Ther\u20081996; 10: 51\u20136.","DOI":"10.1046\/j.1365-2036.1996.22164005.x"},{"key":"2022061701472023400_B48","doi-asserted-by":"crossref","unstructured":"Andrew A, Wyatt JI, Dixon MF. Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology\u20081994; 25: 317\u201322.","DOI":"10.1111\/j.1365-2559.1994.tb01349.x"},{"key":"2022061701472023400_B49","doi-asserted-by":"crossref","unstructured":"Satoh K, Kimura K, Taniguchi Y, et al. Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis. Am J Gastroenterol\u20081998; 93: 569\u201373.","DOI":"10.1111\/j.1572-0241.1998.166_b.x"},{"key":"2022061701472023400_B50","doi-asserted-by":"crossref","unstructured":"Storskrubb T, Aro P, Ronkainen J, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol\u20082008; 43: 1448\u201355.","DOI":"10.1080\/00365520802273025"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/7\/2973\/2622876\/2973.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/7\/2973\/2622876\/2973.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T08:44:18Z","timestamp":1655455458000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/7\/2973\/552976\/Association-between-Chronic-Atrophic-Gastritis-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2009,4,1]]},"published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-3477","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}